Hefei Lifeon Pharmaceutical (003020.SZ) Methorphan Hydrochloride raw material drug listing application accepted

27/12/2024

GMT Eight

Hefei Lifeon Pharmaceutical (003020.SZ) announced that the company has received the "Notice of Acceptance" for the application for the listing of methylphenidate hydrochloride raw materials issued by the National Medical Products Administration. Methylphenidate hydrochloride is a central nervous system stimulant used for the treatment of attention deficit hyperactivity disorder (ADHD).

Leshan Electric Power (600644.SH) has obtained approval from the Shanghai Stock Exchange for its application for a simple program for additional issuance in 2024.

Manshing Global (08309) completes the acquisition of Hong Kong property.

Contact: contact@gmteight.com

Hefei Lifeon Pharmaceutical (003020.SZ) Methorphan Hydrochloride raw material drug listing application accepted

RECOMMEND

HK Stock Market Move | KUNLUN ENERGY (00135) falls by more than 4% again. Warm winter may affect natural gas demand. Citigroup expects management to provide conservative sales guidance for this year.

Lyon: Raised Cathay Pacific Airways (00293) target price to HK$10.1, downgraded rating to "hold"

HK Stock Market Move | SHENZHOU INTL (02313) falls nearly 3% in the afternoon, Macquarie says wage increases will temporarily impact profits, and product average prices are expected to narrow their decline.